Company Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Real-time Estimate Cboe Europe 06:14:59 2024-04-16 am EDT 5-day change 1st Jan Change
222.4 CHF -1.22% Intraday chart for Roche Holding AG +0.32% -9.00%

Business Summary

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees: 103,605

Sales per Business

CHF in Million2022Weight2023Weight Delta
Pharmaceuticals
76.6 %
48,628 73.2 % 46,279 76.6 % -4.83%
Diagnostics
23.4 %
17,798 26.8 % 14,162 23.4 % -20.43%

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
46.9 %
29,313 44.1 % 28,352 46.9 % -3.28%
Rest of Europe
16.1 %
10,328 15.5 % 9,703 16.1 % -6.05%
Rest of Asia
14.7 %
9,852 14.8 % 8,890 14.7 % -9.76%
Japan
7.4 %
6,452 9.7 % 4,464 7.4 % -30.81%
Latin America
4.9 %
2,870 4.3 % 2,971 4.9 % +3.52%
Germany
4.8 %
3,318 5.0 % 2,893 4.8 % -12.81%
Africa, Australia and Oceania
2.0 %
1,520 2.3 % 1,212 2.0 % -20.26%
Switzerland
1.8 %
1,671 2.5 % 1,118 1.8 % -33.09%
Rest of North America
1.4 %
1,102 1.7 % 838 1.4 % -23.96%

Managers

Managers TitleAgeSince
Chief Executive Officer 49 02-12-31
Chairman 57 07-12-31
Director of Finance/CFO 57 11-03-31
Compliance Officer 51 19-12-31
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Corporate Officer/Principal 49 14-12-31
Corporate Secretary 54 20-03-31
General Counsel 60 20-03-31
Human Resources Officer 57 -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 72 15-03-02
Director/Board Member 59 -
Director/Board Member 65 95-12-31
Director/Board Member 56 20-03-16
Corporate Officer/Principal 67 19-03-04
Chairman 57 07-12-31
Director/Board Member 55 17-03-13
Director/Board Member 71 15-03-02
Director/Board Member 58 16-02-29
Director/Board Member 40 20-03-16

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,691,000 28,989,189 ( 27.17 %) 0 88.91 %
Stock B 1 702,562,700 690,550,124 ( 98.29 %) 12,011,755 ( 1.710 %)

Shareholders

NameEquities%Valuation
10,073,029 1.434 % 2 569 M CHF
MFS International (UK) Ltd.
0.5987 %
4,206,054 0.5987 % 1 073 M CHF
Swedbank Robur Fonder AB
0.3107 %
2,182,825 0.3107 % 557 M CHF
March Asset Management SGIIC SAU
0.2754 %
1,934,990 0.2754 % 493 M CHF
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2340 %
1,644,320 0.2340 % 419 M CHF
MFS International Singapore Pte. Ltd.
0.2249 %
1,579,717 0.2249 % 403 M CHF
State Street Global Advisors Ltd.
0.2145 %
1,506,837 0.2145 % 384 M CHF
CapitalatWork SA
0.1965 %
1,380,872 0.1965 % 352 M CHF
Swisscanto Fondsleitung AG
0.1907 %
1,339,459 0.1907 % 342 M CHF
Nordea Investment Management AB
0.1879 %
1,320,423 0.1879 % 337 M CHF
NameEquities%Valuation
MFS Investment Management Canada Ltd.
0.0493 %
2,768,432 0.0493 % 88 M CHF
Saratoga Research & Investment Management
0.0409 %
2,300,436 0.0409 % 73 M CHF
Pacer Advisors, Inc.
0.0196 %
1,099,659 0.0196 % 35 M CHF
NLG Capital, Inc.
0.0129 %
724,880 0.0129 % 23 M CHF
Van Kampen Asset Management
0.009381 %
527,280 0.009381 % 17 M CHF
Financial Gravity Asset Management, Inc.
0.009207 %
517,463 0.009207 % 17 M CHF
MFS International (UK) Ltd.
0.008446 %
474,717 0.008446 % 15 M CHF
Boston Common Asset Management LLC
0.008147 %
457,875 0.008147 % 15 M CHF
Truffle Asset Management (Pty) Ltd.
0.004877 %
274,100 0.004877 % 9 M CHF
Old National Bank (Investment Management)
0.004346 %
244,290 0.004346 % 8 M CHF
NameEquities%Valuation
69,318,000 64.97 % 18 701 M CHF
Maja Oeri
7.584 %
8,091,900 7.584 % 2 183 M CHF
244,786 0.2294 % 66 M CHF
Rothschild & Co. Bank AG
0.1893 %
202,000 0.1893 % 54 M CHF
Ignis Investment Services Ltd.
0.1660 %
177,114 0.1660 % 48 M CHF
Goldman Sachs Advisors BV
0.1574 %
167,973 0.1574 % 45 M CHF
Pareto Asset Management AS
0.1492 %
159,150 0.1492 % 43 M CHF
zCapital AG
0.1087 %
116,000 0.1087 % 31 M CHF
ODDO BHF Trust GmbH
0.0964 %
102,850 0.0964 % 28 M CHF
Aberdeen Standard Investments (Japan) Ltd.
0.0540 %
57,600 0.0540 % 16 M CHF

Holdings

NameEquities%Valuation
1,005,670,000 59.89% 38,367,557,531 $
10,073,029 1.43% 2,568,862,838 $
2,744,120 8.17% 38,884,180 $
454,961 3.02% 13,357,655 $
11,025,941 15.19% 10,805,422 $
1,893 0.06% 1,893 $

Company contact information

Roche Holding AG

Grenzacherstrasse 124

4058, Basel

+41 61 688 11 11

http://www.roche.com
address Roche Holding AG(ROG)

Group companies

NameCategory and Sector
Sapac Corp. Ltd.
Medical Distributors
Roche Finance Europe BV
Finance/Rental/Leasing
Roche Catalyst Investments Ltd.
Roche Financial Investments Ltd.
Roche Intertrade Ltd.
Medical Specialties
Viewics India Pvt Ltd.
Roche Financial Management Ltd.

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225 CHF
Average target price
281.3 CHF
Spread / Average Target
+25.01%
Consensus
  1. Stock Market
  2. Equities
  3. ROG Stock
  4. Company Roche Holding AG